99mTc-Medronate (MDP)
Background Bone metastases are common in patients with advanced malignancies. Autopsy series have shown an incidence of approximately 70% in breast and prostate cancer and… Read More »99mTc-Medronate (MDP)
Background Bone metastases are common in patients with advanced malignancies. Autopsy series have shown an incidence of approximately 70% in breast and prostate cancer and… Read More »99mTc-Medronate (MDP)